According to a news source, India’s Department of Pharmaceuticals will meet with industry associations and the Medical Council of India on July 18, 2012, to consider whether more stringent marketing rules should be imposed on drug manufacturers. In 2011, the department apparently introduced voluntary standards to restrict pharmaceutical companies from offering to physicians and suppliers gifts, pecuniary incentives or benefits in kind, including travel, sporting and leisure activities. Due to ongoing complaints about such practices, a government spokesperson reportedly said, “The department has, therefore, decided to review the situation and speak to various industry associations. If required, it may also make the code of conduct mandatory.” The 12,000 pharmaceutical companies that sell drugs in India are not permitted to advertise prescription products, thus sales are apparently driven by physicians and chemists. See Business Standard, July 8, 2012.
Register Now As you are not an existing subscriber please register for your free daily legal newsfeed service.
RegisterIf you have any questions about the service please contact customerservices@lexology.com or call Lexology Customer Services on +44 20 7234 0606.
India may tighten drug marketing code
- Shook Hardy & Bacon LLP
- John D. Garretson, Patrick Henderson, Chris A. Johnson, Madeleine McDonough and Thomas T. Moga
- India
- July 12 2012
-
If you are interested in submitting an article to Lexology, please contact Andrew Teague at ateague@lexology.com.
![]()
Edward J. Willey III
Corporate Counsel
Huawei Technologies (USA)